106 related articles for article (PubMed ID: 26009309)
1. Elevated expression of the retinoic acid-metabolizing enzyme CYP26C1 in primary breast carcinomas.
Osanai M; Lee GH
Med Mol Morphol; 2016 Mar; 49(1):22-7. PubMed ID: 26009309
[TBL] [Abstract][Full Text] [Related]
2. CYP26C1 Is a Hydroxylase of Multiple Active Retinoids and Interacts with Cellular Retinoic Acid Binding Proteins.
Zhong G; Ortiz D; Zelter A; Nath A; Isoherranen N
Mol Pharmacol; 2018 May; 93(5):489-503. PubMed ID: 29476041
[TBL] [Abstract][Full Text] [Related]
3. A novel human cytochrome P450, CYP26C1, involved in metabolism of 9-cis and all-trans isomers of retinoic acid.
Taimi M; Helvig C; Wisniewski J; Ramshaw H; White J; Amad M; Korczak B; Petkovich M
J Biol Chem; 2004 Jan; 279(1):77-85. PubMed ID: 14532297
[TBL] [Abstract][Full Text] [Related]
4. Expression of retinoic acid-metabolizing enzymes, ALDH1A1, ALDH1A2, ALDH1A3, CYP26A1, CYP26B1 and CYP26C1 in canine testis during post-natal development.
Kasimanickam VR
Reprod Domest Anim; 2016 Dec; 51(6):901-909. PubMed ID: 27569851
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of the retinoic acid-metabolizing enzyme CYP26A1 during the progression of cervical squamous neoplasia and head and neck cancer.
Osanai M; Lee GH
BMC Res Notes; 2014 Oct; 7():697. PubMed ID: 25294402
[TBL] [Abstract][Full Text] [Related]
6. The retinoic acid-metabolizing enzyme CYP26A1 upregulates fascin and promotes the malignant behavior of breast carcinoma cells.
Osanai M; Lee GH
Oncol Rep; 2015 Aug; 34(2):850-8. PubMed ID: 26058854
[TBL] [Abstract][Full Text] [Related]
7. Functional properties and substrate characterization of human CYP26A1, CYP26B1, and CYP26C1 expressed by recombinant baculovirus in insect cells.
Helvig C; Taimi M; Cameron D; Jones G; Petkovich M
J Pharmacol Toxicol Methods; 2011; 64(3):258-63. PubMed ID: 21906690
[TBL] [Abstract][Full Text] [Related]
8. Correlation between genetic and biological aspects in primary non-metastatic breast cancers and corresponding synchronous axillary lymph node metastasis.
D'Andrea MR; Limiti MR; Bari M; Zambenedetti P; Montagutti A; Ricci F; Pappagallo GL; Sartori D; Vinante O; Mingazzini PL
Breast Cancer Res Treat; 2007 Mar; 101(3):279-84. PubMed ID: 16835704
[TBL] [Abstract][Full Text] [Related]
9. Lineage-specific duplication of amphioxus retinoic acid degrading enzymes (CYP26) resulted in sub-functionalization of patterning and homeostatic roles.
Carvalho JE; Theodosiou M; Chen J; Chevret P; Alvarez S; De Lera AR; Laudet V; Croce JC; Schubert M
BMC Evol Biol; 2017 Jan; 17(1):24. PubMed ID: 28103795
[TBL] [Abstract][Full Text] [Related]
10. Biochemical and physiological importance of the CYP26 retinoic acid hydroxylases.
Isoherranen N; Zhong G
Pharmacol Ther; 2019 Dec; 204():107400. PubMed ID: 31419517
[TBL] [Abstract][Full Text] [Related]
11. CYP26A1 and CYP26C1 cooperatively regulate anterior-posterior patterning of the developing brain and the production of migratory cranial neural crest cells in the mouse.
Uehara M; Yashiro K; Mamiya S; Nishino J; Chambon P; Dolle P; Sakai Y
Dev Biol; 2007 Feb; 302(2):399-411. PubMed ID: 17067568
[TBL] [Abstract][Full Text] [Related]
12. The expression and prognostic significance of retinoic acid metabolising enzymes in colorectal cancer.
Brown GT; Cash BG; Blihoghe D; Johansson P; Alnabulsi A; Murray GI
PLoS One; 2014; 9(3):e90776. PubMed ID: 24608339
[TBL] [Abstract][Full Text] [Related]
13. The role of CXCR4 receptor expression in breast cancer: a large tissue microarray study.
Salvucci O; Bouchard A; Baccarelli A; Deschênes J; Sauter G; Simon R; Bianchi R; Basik M
Breast Cancer Res Treat; 2006 Jun; 97(3):275-83. PubMed ID: 16344916
[TBL] [Abstract][Full Text] [Related]
14. Generating gradients of retinoic acid in the chick embryo: Cyp26C1 expression and a comparative analysis of the Cyp26 enzymes.
Reijntjes S; Gale E; Maden M
Dev Dyn; 2004 Jul; 230(3):509-17. PubMed ID: 15188435
[TBL] [Abstract][Full Text] [Related]
15. Expression of glycodelin in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastases.
Shabani N; Mylonas I; Kunert-Keil C; Briese V; Janni W; Gerber B; Friese K; Jeschke U
Anticancer Res; 2005; 25(3A):1761-4. PubMed ID: 16033096
[TBL] [Abstract][Full Text] [Related]
16. p53 in node-negative breast carcinoma: an immunohistochemical study of epidemiologic risk factors, histologic features, and prognosis.
Rosen PP; Lesser ML; Arroyo CD; Cranor M; Borgen P; Norton L
J Clin Oncol; 1995 Apr; 13(4):821-30. PubMed ID: 7707107
[TBL] [Abstract][Full Text] [Related]
17. [Cytoplasmic expression of aquaporin-1 in breast cancer cells and its relationship with clinicopathological characteristics and prognosis].
Zhang B; Liu FF; Ma YJ; Gu F
Zhonghua Zhong Liu Za Zhi; 2013 Dec; 35(12):904-9. PubMed ID: 24506959
[TBL] [Abstract][Full Text] [Related]
18. Nicotine-mediated suppression of the retinoic acid metabolizing enzyme CYP26A1 limits the oncogenic potential of breast cancer.
Osanai M; Lee GH
Cancer Sci; 2011 Jun; 102(6):1158-63. PubMed ID: 21371177
[TBL] [Abstract][Full Text] [Related]
19. Differential immunostaining of various types of breast carcinomas for growth hormone-releasing hormone receptor - Apocrine epithelium and carcinomas emerging as uniformly positive.
Kővári B; Rusz O; Schally AV; Kahán Z; Cserni G
APMIS; 2014 Sep; 122(9):824-31. PubMed ID: 24479854
[TBL] [Abstract][Full Text] [Related]
20. CYP26A1 and CYP26C1 cooperate in degrading retinoic acid within the equatorial retina during later eye development.
Sakai Y; Luo T; McCaffery P; Hamada H; Dräger UC
Dev Biol; 2004 Dec; 276(1):143-57. PubMed ID: 15531370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
